Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
---|
09/22/2010 | EP1194449B1 Inhibitors of memapsin 2 and use thereof |
09/22/2010 | CN201586232U Vitamin C fructus forsythiae soft capsule |
09/22/2010 | CN201585460U Multifunctional pillow health care cap |
09/22/2010 | CN1943716B A Chinese traditional medicinal composition for brain tuning and nerves soothing and its preparation method |
09/22/2010 | CN1893961B Biologically active blood serum obtained by electroshock |
09/22/2010 | CN1545422B Compositions and methods for enhanced pharmacological activity through oral and parenteral administration of compositions comprising polypeptide drug substances and other poorly absorbed active ingred |
09/22/2010 | CN101842388A Humanized antibodies against the beta-amyloyd peptide |
09/22/2010 | CN101842372A Pyridyl sulfonamides as modulators of ion channels |
09/22/2010 | CN101842371A 3-methyl-2- ( (2s) -2- (4- (3-methyl-l, 2, 4-0xadiaz0l-5-yl) phenyl) morpholino) -6- (pyrimidin-4-yl) pyrimidin-4 (3h) -one as tau protein kinase inhibitor |
09/22/2010 | CN101842369A 2,3-dihydrobenzo(1,4) dioxin-2-ylmethyl derivatives as alpha2C antagonists for use in the treatment of peripheric and central nervous system diseases |
09/22/2010 | CN101842364A Sulfamide derivative useful for the treatment of epilepsy |
09/22/2010 | CN101842354A Catecholamine derivatives and prodrugs thereof |
09/22/2010 | CN101842103A Unit dosage for brain health |
09/22/2010 | CN101838328A Anti-vegf antibodies |
09/22/2010 | CN101838269A 1,3,8-triaza-spiro[4.5]decane-4-ketone compounds and pharmaceutical application thereof |
09/22/2010 | CN101838260A Dihydropyrrolones derivative as Caspase-3 inhibitor |
09/22/2010 | CN101838202A Total terpenoids of ferula dissecta as well as medical application and preparation method thereof |
09/22/2010 | CN101837140A Pasteurisation process for microbial cells and microbial oil |
09/22/2010 | CN101837139A Pasteurisation process for microbial cells and microbial oil |
09/22/2010 | CN101837138A Pasteurisation process for microbial cells and microbial oil |
09/22/2010 | CN101837137A Pasteurisation process for microbial cells and microbial oil |
09/22/2010 | CN101837136A Pasteurisation process for microbial cells and microbial oil |
09/22/2010 | CN101837135A Pasteurisation process for microbial cells and microbial oil |
09/22/2010 | CN101837109A Foot-bath effervescent tablet for improving sleep |
09/22/2010 | CN101837091A Process for continuously extracting polygonatum saponin and polygonatum polysaccharose |
09/22/2010 | CN101837090A Chinese medicinal composition for curing cardiac neurosis |
09/22/2010 | CN101837080A Oolong spur eliminating paste |
09/22/2010 | CN101837075A Composition for preventing and treating dementia |
09/22/2010 | CN101837066A Application of golden thread detoxication decoction as compound preparation in preparing IOD active medicaments |
09/22/2010 | CN101837042A Preparation method of Flos albiziae wine |
09/22/2010 | CN101837032A Blueberry anthocyanin oral solution |
09/22/2010 | CN101837030A Thuja extract and application thereof in preparation of medicaments for preventing and treating neurodegenerative diseases |
09/22/2010 | CN101837024A Quick-acting medicament for curing tic disorder disease |
09/22/2010 | CN101837000A Application of 2-fluroin-beta-D-glycoside in treating neuropathic pain |
09/22/2010 | CN101836974A Rivastigmine-hydrogentartrate-containing pharmaceutical composition and preparation method |
09/22/2010 | CN101836966A Agomelatine-containing orally disintegrating tablet |
09/22/2010 | CN101306074B Anti-alcohol and liver- protection medicine composition |
09/22/2010 | CN101172103B Medicament for treating multiple diseases such as climacteric syndrome and osteoporosis of women |
09/21/2010 | US7799931 Spirocyclic cyclohexane compounds |
09/21/2010 | US7799913 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses |
09/21/2010 | US7799832 Especially tolperisone or its analogs eperisone or silperisone, or riluzole, propafenone, lidocaine, flecainide or metixen or their salts; treating pains which are accompanied by an increase in muscle tone |
09/21/2010 | US7799830 fewer side-effects by showing no hormone properties; enhancing the learning and memory-retention, treat dementia |
09/21/2010 | US7799827 zearalenone-like macrolides, used to to inhibit nuclear factor kappa-beta (NF- kappa B) activation, as sucnscreen agents and in the treatment of inflammatory or autoimmune disorders and disorders involving malignancy or increased angiogenesis |
09/21/2010 | US7799794 Treatment for cardiovascular disease |
09/21/2010 | US7799786 Therapeutic agents useful for treating pain |
09/21/2010 | US7799785 such as (4aS,13bR,14aR)-6-fluoro-1,4a,9,13b,14,14a-hexahydrodibenzo[3',4':6',7']-cyclohepta[1',2':4,5]pyrrolo[1,2-c]imidazole-3(2H)-thione, having binding affinities towards serotonin receptors, dopamine receptors and with norepinephrine reuptake inhibition properties; antidepressants; neuroleptic agents |
09/21/2010 | US7799775 Pyrimidine derivatives |
09/21/2010 | US7799774 Quinoline derivatives and their use as 5-HT6 ligands |
09/21/2010 | US7799773 administering 7-Benzyloxy-3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine, for the treatment of Alzheimer's disease, cognitive impairment, dementia, epilepsy, neuropathic pain, Parkinson's disease, schizophrenia, attention deficit disorder or depression in humans |
09/21/2010 | US7799771 solid dosage form for contraceptives and hormone replacement therapy; very low moisture content to prevent ester hydrolysis; enhanced bioavailability of 17-beta-estradiol acetate; FDA Orange book listed patent for estradiol acetate |
09/21/2010 | US7799763 Muscle-strengthening drugs and anti-inflammatory drugs |
09/21/2010 | US7799345 Preparation of injectable suspensions having improved injectability |
09/21/2010 | CA2487165C Cinnamic acid dimers, their preparation and the use thereof for treating neurodegenerative disease |
09/21/2010 | CA2470832C Azaindolylalkylamine derivatives as 5-hydroxytryptamine-6 ligands |
09/21/2010 | CA2451915C Crystalline composition containing escitalopram |
09/21/2010 | CA2445068C Azo compounds for type i phototherapy |
09/21/2010 | CA2440559C Novel non-imidazole compounds |
09/21/2010 | CA2437950C Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical |
09/21/2010 | CA2436225C N-(arylsulphonyl)beta-amino acid derivatives comprising a substituted aminomethyl group, process for preparing them and pharmaceutical compositions containing them |
09/21/2010 | CA2429308C Novel lactam-substituted pyrazolopyridine derivatives |
09/21/2010 | CA2420568C Pharmaceutically active benzsulfonamide derivatives as inhibitors of protein junkinases |
09/21/2010 | CA2416650C Enhancement of the action of central and peripheral nervous system agents |
09/21/2010 | CA2408746C Antisense phosporodiamidate morpholino oligonucleotide inhibition of cytochrome p450 to modulate drug pharmacokinetics |
09/21/2010 | CA2401502C Carboxylic acid derivatives as ip antagonists |
09/21/2010 | CA2386549C Polymorphic b form of 3-(cyclopropylmethoxy)-4-[4-(methylsulfonyl)phenyl]-5,5-dimethyl-5h-furan-2-one |
09/21/2010 | CA2361081C Chaperonin 10 and .beta.-interferon therapy of multiple sclerosis |
09/21/2010 | CA2359948C Triazole compounds with dopamine-d3-receptor affinity |
09/21/2010 | CA2307142C N-terminally chemically modified protein compositions and methods |
09/21/2010 | CA2306692C Dipeptide apoptosis inhibitors and the use thereof |
09/20/2010 | CA2696705A1 New benzothiadiazepine derivatives, preparation method thereof and pharmaceutical compositions containing same |
09/19/2010 | CA2696918A1 Compound for use in the treatment of peripheral neuropathies |
09/16/2010 | WO2010105191A2 Antimicrobial compositions and methods of use therefore |
09/16/2010 | WO2010105189A1 Method for identifying compounds that attenuate the function or reduce abundance of a voltage-gated potassium channel and are associated with maintenance of cognitive function in old age |
09/16/2010 | WO2010105144A2 Method of disease-induced and receptor-mediated stem cell neuroprotection |
09/16/2010 | WO2010105103A1 Compositions and methods for prophylaxis and treatment of addictions |
09/16/2010 | WO2010105093A2 Implantable device for long-term delivery of drugs |
09/16/2010 | WO2010104843A2 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors |
09/16/2010 | WO2010104384A1 Nutritional composition inducing a postprandial endocrine response |
09/16/2010 | WO2010104374A1 Nutritional composition inducing a postprandial endocrine response |
09/16/2010 | WO2010104205A1 7-cycloalkylaminoquinolones as gsk-3 inhibitors |
09/16/2010 | WO2010104114A1 Method for preparing polypeptide library |
09/16/2010 | WO2010104024A1 Piperazine compound capable of inhibiting prostaglandin d synthase |
09/16/2010 | WO2010103204A1 Metal ion chelating agents, methods for preparing same and uses thereof |
09/16/2010 | WO2010103095A1 Tetrahydronaphthalen-2-ol derivatives |
09/16/2010 | WO2010103064A1 Novel benzoxazinone derivatives useful for the treatment of cns disorders |
09/16/2010 | WO2010103039A1 Immediate release pharmaceutical compositions comprising oxycodone and naloxone |
09/16/2010 | WO2010103001A1 Tricyclic heterocyclic derivatives |
09/16/2010 | WO2010102991A2 Riluzole liquid emulsions |
09/16/2010 | WO2010102923A2 Riluzole aqueous suspensions |
09/16/2010 | WO2010102811A1 Substituted 2-mercaptoquinoline-3-carboxamides as kcnq2/3 modulators |
09/16/2010 | WO2010102810A1 Substituted 2-mercapto-3-aminopyridines as kcnq2/3 modulators |
09/16/2010 | WO2010102779A1 Substituted 3-amino-2-mercaptoquinolines as kcnq2/3 modulators |
09/16/2010 | WO2010102778A2 Substituted 3-aminoisoxazolopyridines as kcnq2/3 modulators |
09/16/2010 | WO2010102663A1 Piperazine derivatives for use in therapy |
09/16/2010 | WO2010102554A1 New crystalline form vi of agomelatine, preparation method and application thereof |
09/16/2010 | WO2010102512A1 C-aryl glucoside derivatives, preparation process and pharmaceutical use thereof |
09/16/2010 | WO2010075204A3 Gamma secretase modulators |
09/16/2010 | WO2010065889A3 Cyclobutanemethanamine inhibitors of monomine reuptake |
09/16/2010 | WO2010062900A3 A new family of pain producing substances and methods to produce novel analgesic drugs |
09/16/2010 | WO2010059241A3 Treatment of amyotrophic lateral sclerosis |